The EPS projection of Marvell Technology Group Ltd. (NASDAQ:MRVL) for period quarter completed 2017-01-31 is $0.05.
The EPS estimates pronounced a week and 30 days ago were $0.05 and $0.05 correspondingly. The EPS forecasts specified 60 and 90 days before were $0.05 and $0.05 respectively. From a week ago, the aberration in EPS forecast is 0 percent.
The mean EPS prediction straightaway before the earnings release for the quarter completed 2 is $0.05 based on 8 EPS estimations. The EPS stated on 2016-09-06 was $0.11. The EPS surprise was $0.05, or 83.33 percent. The standard deviation as per known EPS estimates was $0.01.
The positive EPS revisions were 0 a week earlier and negative revisions were 0. In last 30 and 60 days, the positive EPS revisions were 0 and 3 correspondingly, while for 90 and 120 days, revisions count was 0 and 1.
The negative revisions of per-share earnings in the last 30 and 60-days were 0 and 4 in that order. however, for 90 and 120 days’ period, the count was 1 and 1 in that order.
EPS revisions upgrade and downgrade in the last 18 days were 1 and 1 correspondingly.
Quarterly Sales Estimates
The arithmetic mean of probable annual sales of Marvell Technology Group Ltd. (NASDAQ:MRVL) is $607.566 and the median was $607.7. The estimate is stated by 6 analysts for the fiscal 2018.
The highest annual projection is $643 and lowest sales target is $577. This marks a standard deviation of $27.69.
Almost 6 have given revised positive sales forecast in the past week and 6 have downgraded forecasts. As per the stated estimates, the change in target from the past week is -0.202 percent.
Nearly 6 have revised sales projections in positive side over the past month and 6 have downgraded forecasts. This shows a mean estimate deviation of -1.092 percent.
Just about 6 have revised sales forecast on plus side over the quarter and 6 have downgraded forecasts. This shows mean estimate deviation of -1.397 percent.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...